These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19380510)

  • 1. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection.
    Pearson MS; Bethony JM; Pickering DA; de Oliveira LM; Jariwala A; Santiago H; Miles AP; Zhan B; Jiang D; Ranjit N; Mulvenna J; Tribolet L; Plieskatt J; Smith T; Bottazzi ME; Jones K; Keegan B; Hotez PJ; Loukas A
    FASEB J; 2009 Sep; 23(9):3007-19. PubMed ID: 19380510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.
    Pearson MS; Jariwala AR; Abbenante G; Plieskatt J; Wilson D; Bottazzi ME; Hotez PJ; Keegan B; Bethony JM; Loukas A
    Hum Vaccin Immunother; 2015; 11(5):1251-7. PubMed ID: 26018444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis.
    Pearson MS; Pickering DA; Tribolet L; Cooper L; Mulvenna J; Oliveira LM; Bethony JM; Hotez PJ; Loukas A
    J Infect Dis; 2010 May; 201(10):1561-9. PubMed ID: 20367477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adults.
    Diemert DJ; Zumer M; Campbell D; Grahek S; Li G; Peng J; Elena Bottazzi M; Hotez P; Bethony J
    Vaccine; 2022 Oct; 40(42):6084-6092. PubMed ID: 36114129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.
    Adegnika AA; de Vries SG; Zinsou FJ; Honkepehedji YJ; Dejon Agobé JC; Vodonou KG; Bikangui R; Bouyoukou Hounkpatin A; Bache EB; Massinga Loembe M; van Leeuwen R; Molemans M; Kremsner PG; Yazdanbakhsh M; Hotez PJ; Bottazzi ME; Li G; Bethony JM; Diemert DJ; Grobusch MP;
    Lancet Infect Dis; 2021 Feb; 21(2):275-285. PubMed ID: 32926834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.
    Zinsou JF; Diemert DJ; Dejon-Agobé JC; Adégbité BR; Honkpehedji YJ; Vodonou KG; Bikangui R; Edoa JR; Massinga Loembe M; Li G; Yazdanbakhsh M; Bottazzi ME; van Leeuwen R; Kremsner PG; Hotez PJ; Bethony JM; Grobusch MP; Adegnika AA
    Lancet Infect Dis; 2024 Jul; 24(7):760-774. PubMed ID: 38513684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs.
    Loukas A; Bethony JM; Mendez S; Fujiwara RT; Goud GN; Ranjit N; Zhan B; Jones K; Bottazzi ME; Hotez PJ
    PLoS Med; 2005 Oct; 2(10):e295. PubMed ID: 16231975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus.
    Xiao S; Zhan B; Xue J; Goud GN; Loukas A; Liu Y; Williamson A; Liu S; Deumic V; Hotez P
    Exp Parasitol; 2008 Jan; 118(1):32-40. PubMed ID: 17645877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a peptide vaccine against hookworm infection: Immunogenicity, efficacy, and immune correlates of protection.
    Shalash AO; Becker L; Yang J; Giacomin P; Pearson M; Hussein WM; Loukas A; Toth I; Skwarczynski M
    J Allergy Clin Immunol; 2022 Jul; 150(1):157-169.e10. PubMed ID: 35278494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion.
    Williamson AL; Brindley PJ; Abbenante G; Datu BJ; Prociv P; Berry C; Girdwood K; Pritchard DI; Fairlie DP; Hotez PJ; Zhan B; Loukas A
    J Infect Dis; 2003 Feb; 187(3):484-94. PubMed ID: 12552433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-based subunit vaccine against hookworm infection.
    Skwarczynski M; Dougall AM; Khoshnejad M; Chandrudu S; Pearson MS; Loukas A; Toth I
    PLoS One; 2012; 7(10):e46870. PubMed ID: 23056500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.
    Seid CA; Curti E; Jones RM; Hudspeth E; Rezende W; Pollet J; Center L; Versteeg L; Pritchard S; Musiychuk K; Yusibov V; Hotez PJ; Bottazzi ME
    Hum Vaccin Immunother; 2015; 11(6):1474-88. PubMed ID: 25905574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
    Diemert DJ; Freire J; Valente V; Fraga CG; Talles F; Grahek S; Campbell D; Jariwala A; Periago MV; Enk M; Gazzinelli MF; Bottazzi ME; Hamilton R; Brelsford J; Yakovleva A; Li G; Peng J; Correa-Oliveira R; Hotez P; Bethony J
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005574. PubMed ID: 28464026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hookworm burden reductions in BALB/c mice vaccinated with recombinant Ancylostoma secreted proteins (ASPs) from Ancylostoma duodenale, Ancylostoma caninum and Necator americanus.
    Sen L; Ghosh K; Bin Z; Qiang S; Thompson MG; Hawdon JM; Koski RA; Shuhua X; Hotez PJ
    Vaccine; 2000 Jan; 18(11-12):1096-102. PubMed ID: 10590331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development.
    Bouchery T; Filbey K; Shepherd A; Chandler J; Patel D; Schmidt A; Camberis M; Peignier A; Smith AAT; Johnston K; Painter G; Pearson M; Giacomin P; Loukas A; Bottazzi ME; Hotez P; LeGros G
    PLoS Pathog; 2018 Mar; 14(3):e1006931. PubMed ID: 29566094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing a vaccine to prevent hookworm disease and anemia.
    Hotez PJ; Beaumier CM; Gillespie PM; Strych U; Hayward T; Bottazzi ME
    Vaccine; 2016 Jun; 34(26):3001-3005. PubMed ID: 27040400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopeptide-Based Oral Vaccine Against Hookworm Infection.
    Bartlett S; Eichenberger RM; Nevagi RJ; Ghaffar KA; Marasini N; Dai Y; Loukas A; Toth I; Skwarczynski M
    J Infect Dis; 2020 Mar; 221(6):934-942. PubMed ID: 31621864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus.
    Ranjit N; Zhan B; Hamilton B; Stenzel D; Lowther J; Pearson M; Gorman J; Hotez P; Loukas A
    J Infect Dis; 2009 Mar; 199(6):904-12. PubMed ID: 19434933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms.
    Loukas A; Bethony JM; Williamson AL; Goud GN; Mendez S; Zhan B; Hawdon JM; Elena Bottazzi M; Brindley PJ; Hotez PJ
    J Infect Dis; 2004 May; 189(10):1952-61. PubMed ID: 15122534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A history of hookworm vaccine development.
    Schneider B; Jariwala AR; Periago MV; Gazzinelli MF; Bose SN; Hotez PJ; Diemert DJ; Bethony JM
    Hum Vaccin; 2011 Nov; 7(11):1234-44. PubMed ID: 22064562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.